206 related articles for article (PubMed ID: 37524692)
1. Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2.
Zheng Y; Zhan Y; Zhang Y; Zhang Y; Liu Y; Xie Y; Sun Y; Qian J; Ding Y; Ding Y; Fang Y
Cell Death Dis; 2023 Aug; 14(8):488. PubMed ID: 37524692
[TBL] [Abstract][Full Text] [Related]
2. ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis.
Dou C; Mo H; Chen T; Liu J; Zeng Y; Li S; Guo C; Zhang C
Pathol Res Pract; 2021 Mar; 219():153345. PubMed ID: 33517164
[TBL] [Abstract][Full Text] [Related]
3. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein.
Huang M; Xiong H; Luo D; Xu B; Liu H
Exp Cell Res; 2020 Mar; 388(2):111876. PubMed ID: 31991125
[TBL] [Abstract][Full Text] [Related]
4. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
Ding Z; Guo L; Deng Z; Li P
Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection.
Zhang ZF; Feng XS; Chen H; Duan ZJ; Wang LX; Yang D; Liu PX; Zhang QP; Jin YL; Sun ZG; Liu H
BMC Gastroenterol; 2016 Jun; 16(1):57. PubMed ID: 27255554
[TBL] [Abstract][Full Text] [Related]
6. Androgen Receptor Stimulates Hexokinase 2 and Induces Glycolysis by PKA/CREB Signaling in Hepatocellular Carcinoma.
Sun RF; Zhao CY; Chen S; Yu W; Zhou MM; Gao CR
Dig Dis Sci; 2021 Mar; 66(3):802-813. PubMed ID: 32274668
[TBL] [Abstract][Full Text] [Related]
7. Caveolin enhances hepatocellular carcinoma cell metabolism, migration, and invasion in vitro via a hexokinase 2-dependent mechanism.
Chai F; Li Y; Liu K; Li Q; Sun H
J Cell Physiol; 2019 Feb; 234(2):1937-1946. PubMed ID: 30144070
[TBL] [Abstract][Full Text] [Related]
8. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
[TBL] [Abstract][Full Text] [Related]
9. MiR-3662 suppresses cell growth, invasion and glucose metabolism by targeting HK2 in hepatocellular carcinoma cells.
Ye J; Xiao X; Han Y; Fan D; Zhu Y; Yang L
Neoplasma; 2020 Jul; 67(4):773-781. PubMed ID: 32726127
[TBL] [Abstract][Full Text] [Related]
10. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway.
Wu H; Pan L; Gao C; Xu H; Li Y; Zhang L; Ma L; Meng L; Sun X; Qin H
Molecules; 2019 May; 24(10):. PubMed ID: 31137633
[TBL] [Abstract][Full Text] [Related]
11. STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells.
Li M; Jin R; Wang W; Zhang T; Sang J; Li N; Han Q; Zhao W; Li C; Liu Z
Oncotarget; 2017 Apr; 8(15):24777-24784. PubMed ID: 28445971
[TBL] [Abstract][Full Text] [Related]
12. Astragalin Reduces Hexokinase 2 through Increasing miR-125b to Inhibit the Proliferation of Hepatocellular Carcinoma Cells in Vitro and in Vivo.
Li W; Hao J; Zhang L; Cheng Z; Deng X; Shu G
J Agric Food Chem; 2017 Jul; 65(29):5961-5972. PubMed ID: 28654261
[TBL] [Abstract][Full Text] [Related]
13. Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc/hexokinase 2 pathway.
Yu Q; Dai W; Ji J; Wu L; Feng J; Li J; Zheng Y; Li Y; Cheng Z; Zhang J; Wu J; Xu X; Guo C
J Cell Mol Med; 2022 May; 26(10):3031-3045. PubMed ID: 35429101
[TBL] [Abstract][Full Text] [Related]
14. Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma.
Yoo JJ; Yu SJ; Na J; Kim K; Cho YY; Lee YB; Cho EJ; Lee JH; Kim YJ; Youn H; Yoon JH
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875800
[TBL] [Abstract][Full Text] [Related]
15. Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma.
Lee HG; Kim H; Son T; Jeong Y; Kim SU; Dong SM; Park YN; Lee JD; Lee JM; Park JH
Oncotarget; 2016 Jul; 7(27):41798-41810. PubMed ID: 27260001
[TBL] [Abstract][Full Text] [Related]
16. Vaccinia-related kinase 2 blunts sorafenib's efficacy against hepatocellular carcinoma by disturbing the apoptosis-autophagy balance.
Chen S; Du Y; Xu B; Li Q; Yang L; Jiang Z; Zeng Z; Chen L
Oncogene; 2021 May; 40(19):3378-3393. PubMed ID: 33875785
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ribosomal RNA processing 15 Homolog (RRP15), which is overexpressed in hepatocellular carcinoma, suppresses tumour growth via induction of senescence and apoptosis.
Zhao D; Qian L; Zhuang D; Wang L; Cao Y; Zhou F; Zhang S; Liu Y; Liang Y; Zhang W; Kang W; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Xu G; Lv Y; Zou X; Zhuge Y; Zhang B
Cancer Lett; 2021 Oct; 519():315-327. PubMed ID: 34343634
[TBL] [Abstract][Full Text] [Related]
18. [The role of hexokinase 2 in the metastasis of hepatocellular carcinoma cells].
Geng XL; Long WH; Hai J; Zhang Y; Zheng W; Zhang ZY; Du LX
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):739-742. PubMed ID: 27784456
[No Abstract] [Full Text] [Related]
19. The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma.
Jin F; Wang Y; Zhu Y; Li S; Liu Y; Chen C; Wang X; Zen K; Li L
Sci Rep; 2017 Jun; 7(1):3089. PubMed ID: 28596599
[TBL] [Abstract][Full Text] [Related]
20. MiR-92b targets p57kip2 to modulate the resistance of hepatocellular carcinoma (HCC) to ionizing radiation (IR) -based radiotherapy.
Wang J; Zhao H; Yu J; Xu X; Liu W; Jing H; Li N; Tang Y; Li Y; Cai J; Jin J
Biomed Pharmacother; 2019 Feb; 110():646-655. PubMed ID: 30544064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
